RPG Life Sciences Ltd

📊 RPG Life Sciences Board to Review FY2026 Results & Dividend on April 29

• Board meeting scheduled for April 29, 2026

• Will review and approve audited standalone and consolidated financial results for Q4 and FY ending March 31, 2026

• Will recommend dividend on equity shares for FY 2025-26 if applicable

• Trading window closed from April 1, 2026 until 48 hours after results declaration